Advertisement

Oral Cavity and Oropharynx

  • Joseph L. Edmonds
  • Sheena Pimpalwar
Chapter

Abstract

Three vascular lesions are commonly encountered in the oropharynx. These are hemangioma, venous malformation, and lymphatic malformation. A fourth type of vascular anomaly, arteriovenous malformation, may also occur in the oropharynx but only as an extension of a nearby larger lesion. As such, it is better considered outside of the anatomic subsection of the oropharynx. Each of these three types will be discussed separately with respect to phenotype, etiology, natural history, and treatment.

Keywords

Tongue Bleeding Pain Laser Medical Occlusion 

Notes

To assist the reader in gaining familiarity with available evidence, the following rating system has been used to indicate key references for each chapter’s content:

***: Critical material. Anyone dealing with this condition should be familiar with this reference.

**: Useful material. Important information that is valuable in in clinical or scientific practice related to this condition.

*: Optional material. For readers with a strong interest in the chapter content or a desire to study it in greater depth.

References

  1. 1.
    O TM, Alexander RE, Lando T, Grant NN, Perkins JA, Blitzer A, Waner M. Segmental hemangiomas of the upper airway. Laryngoscope. 2009;119(11):2242–7.  https://doi.org/10.1002/lary.20666.CrossRefPubMedGoogle Scholar
  2. 2.
    ***Garzon MC, Epstein LG, Heyer GL, Frommelt PC, Orbach DB, Baylis AL, Blei F, Burrows PE, Chamlin SL, Chun RH, Hess CP, Joachim S, Johnson K, Kim W, Liang MG, Maheshwari M, McCoy GN, Metry DW, Monrad PA, Pope E, Powell J, Shwayder TA, Siegel DH, Tollefson MM, Vadivelu S, Lew SM, Frieden IJ, Drolet BA. PHACE syndrome: consensus-derived diagnosis and care recommendations. J Pediatr. 2016;178:24–33.e2.  https://doi.org/10.1016/j.jpeds.2016.07.054. Epub 2016 Sep 19.CrossRefPubMedGoogle Scholar
  3. 3.
    McCuaig CC, Cohen L, Powell J, Hatami A, Marcoux D, Maari C, Caouette-Laberge L, Bortoluzzi P, Ondrejchak S, Dubois J. Therapy of ulcerated hemangiomas. J Cutan Med Surg. 2013;17(4):233–42.CrossRefGoogle Scholar
  4. 4.
    Metz BJ, Rubenstein MC, Levy ML, Metry DW. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol. 2004;140(7):867–70.CrossRefGoogle Scholar
  5. 5.
    *David LR, Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003;56(4):317–27.CrossRefGoogle Scholar
  6. 6.
    Rizzo C, Brightman L, Chapas AM, Hale EK, Cantatore-Francis JL, Bernstein LJ, Geronemus RG. Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: a retrospective chart analysis. Dermatol Surg. 2009;35(12):1947–54.  https://doi.org/10.1111/j.1524-4725.2009.01356.x.CrossRefPubMedGoogle Scholar
  7. 7.
    Li Y, Hu Y, Li H, Deng L. Successful treatment of ulcerated hemangiomas with a dual-wavelength 595- and 1064-nm laser system. J Dermatolo Treat. 2016;27(6):562–7. Epub 2016 Apr 13.CrossRefGoogle Scholar
  8. 8.
    **van der Vieuten CJ, Kater A, Wijnen MH, Schultze Kool LJ, Rovers MM. Effectiveness of sclerotherapy, surgery and laser therapy in patients with venous malformations: a systemic review. Cardiovasc Intervent Radiol. 2014;37(4):977–89.Google Scholar
  9. 9.
    Xue L, Cao RY, Xu DP, Sun NN, Tan HS, Wang XK. Percutaneous treatment of large venous malformations in the oral and maxillofacial regions using electrochemical therapy combined with pingyangmycin. J Oral Maxillofac Surg. 2015;73(7):1384–91.  https://doi.org/10.1016/j.joms.2015.01.020. Epub 2015 Jan 30.CrossRefPubMedGoogle Scholar
  10. 10.
    McMorrow L, Shaikh M, Kessell G, Muir T. Bleomycin electrosclerotherapy: new treatment to manage vascular malformations. Br J Oral Maxillofac Surg. 2017;55(9):977–9.  https://doi.org/10.1016/j.bjoms.2017.10.002. Epub 2017 Oct 18.CrossRefPubMedGoogle Scholar
  11. 11.
    Wang D, Su L, Han Y, Wang Z, Zheng L, Li J, Fan X. Direct intralesional ethanol sclerotherapy of extensive venous malformations with oropharyngeal involvement after a temporary tracheotomy in the head and neck: initial results. Head Neck. 2017;39(2):288–96.  https://doi.org/10.1002/hed.24588. Epub 2016 Sep 22.CrossRefPubMedGoogle Scholar
  12. 12.
    **Asdahl KR, Hedelund L, Keller J, Baad-Hansen T, Damsgaard T. Outcome measures after sclerotherapy of venous malformations: a systematic review. Cardiovasc Intervent Radiol. 2018.  https://doi.org/10.1007/s00270-018-1919-y. [Epub ahead of print].CrossRefGoogle Scholar
  13. 13.
    Mungnirandr A, Nuntasunti W, Manuskiatti W. Neodymium-doped yttrium aluminium garnet laser treatment of pediatric venous malformation in the oral cavity. Dermatol Surg. 2016;42(7):875–9.  https://doi.org/10.1097/DSS.0000000000000770.CrossRefPubMedGoogle Scholar
  14. 14.
    Stefini S, Bazzana T, Smussi C, Piccioni M, Frusca T, Taddei F, Tomasoni G, Recupero D, Cavazza A, Villani P, Nicolai P, Eivazi B, Wiegand S, Werner JA, Schmidt S, Maier RF, Torossian A. EXIT (Ex utero intrapartum treatment) in lymphatic malformations of the head and neck: discussion of three cases and proposal of an EXIT-TTP (team time procedure) list. Int J Pediatr Otorhinolaryngol. 2012;76(1):20–7.  https://doi.org/10.1016/j.ijporl.2011.09.015. Epub 2011 Nov 10.CrossRefPubMedGoogle Scholar
  15. 15.
    Adams MR, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: a systematic review. Otolayngol Head Neck Surg. 2012;147(4):627–39.CrossRefGoogle Scholar
  16. 16.
    **Balakrishnan K, Menezes MD, Chen BS, Magit AE, Perkins JA. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations. JAMA Otolaryngol Head Neck Surg. 2014;140(1):41–5.  https://doi.org/10.1001/jamaoto.2013.5849.CrossRefPubMedGoogle Scholar
  17. 17.
    Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds JL Jr, Hoffer FA, Egbert MA. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg. 2010;142(6):795–803, 803.e1.  https://doi.org/10.1016/j.otohns.2010.02.026.CrossRefPubMedGoogle Scholar
  18. 18.
    Kim DW. OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome. Pediatr Radiol. 2014;44(7):857–62.  https://doi.org/10.1007/s00247-014-2889-0. Epub 2014 Feb 26.CrossRefPubMedGoogle Scholar
  19. 19.
    Cheng J. Doxycycline sclerotherapy in children with head and neck lymphatic malformations. Pediatr Surg. 2015;50(12):143–6.CrossRefGoogle Scholar
  20. 20.
    Bai Y, Jia J, Huang XX, Alsharif MH, Zhao JH, Zhao YF. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg. 2009;67(2):251–6.CrossRefGoogle Scholar
  21. 21.
    *Oomen KP, Paramasivam S, Waner M, Niimi Y, Fifi JT, Berenstein A, O TM. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations. Laryngoscope. 2016;126(1):205–11.  https://doi.org/10.1002/lary.25284. Epub 2015 May 13.CrossRefGoogle Scholar
  22. 22.
    Chakravarti A, Bhargava R. Lymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin. Int J Pediatr Otorhinolaryngol. 2013;77(8):1367–9.  https://doi.org/10.1016/j.ijporl.2013.05.009. Epub 2013 May 31.CrossRefPubMedGoogle Scholar
  23. 23.
    Hwang J, Lee YK, Burm JS. Treatment of tongue lymphangioma with intralesional combination injection of steroid, bleomycin and bevacizumab. Arch Craniofac Surg. 2017;18(1):54–8.  https://doi.org/10.7181/acfs.2017.18.1.54. Epub 2017 Mar 25.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Mai HM, Zheng JW, Zhou Q, Yang XJ, Wang YA, Fan XD. Intralesional injection of pingyangmycin is a safe and effective treatment for microcystic lymphatic malformations in the tongue. Phlebology. 2013;28(3):147–52.CrossRefGoogle Scholar
  25. 25.
    Renton JP, Smith RJ. Current treatment paradigms in the management of lymphatic malformations. Laryngoscope. 2011;121(1):56–9.CrossRefGoogle Scholar
  26. 26.
    Kaufman Y, Cole P, McKnight A, Hatef DA, Hollier L, Edmonds J. A modified keyhole technique for correction of macroglossia. Plast Reconstr Surg. 2008;122(6):1867–9.CrossRefGoogle Scholar
  27. 27.
    Grimmer JF, Mulliken JB, Burrows PE, Rahbar R. Radiofrequency ablation of microcystic lymphatic malformation in the oral cavity. Arch Otolaryngol Head Neck Surg. 2006;132(11):125–6.CrossRefGoogle Scholar
  28. 28.
    Thottam PJ, Al-Barazi R, Madgy DN, Rozzelle A. Submucosal resection of a microcystic oropharyngeal lymphatic malformation using radiofrequency ablation. Int J Pediatr Otorhinolaryngol. 2013;77(9):1589–92.CrossRefGoogle Scholar
  29. 29.
    Balakrishnan K, Edwards TC, Perkins JA. Functional and symptom impacts of pediatric head and neck lymphatic malformations: developing a patient-derived instrument. Otolaryngol Head Neck Surg. 2012;147(5):925–31.  https://doi.org/10.1177/0194599812450838. Epub 2012 Jun 6.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Joseph L. Edmonds
    • 1
    • 2
  • Sheena Pimpalwar
    • 3
  1. 1.Division of OtolaryngologyTexas Children’s HospitalHoustonUSA
  2. 2.Baylor College of MedicineChildren’s ENT of HoustonHoustonUSA
  3. 3.Department of RadiologyBaylor College of Medicine, Texas Children’s HospitalHoustonUSA

Personalised recommendations